Deborah B Adey, MD

Offices

1 location · Regents of the University of California · 706 clinicians in this group

Looking this up.

Hospitals listed: UCSF Medical Center. That is not proof they admit you there this week.

Plans that list them

9 plans · 1 carrier

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Adey’s office at (415) 476-4029 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

Sort by

Plans whose provider directory lists this clinician

Alignment Health BreathEasy (HMO C-SNP)	Alignment Health Plan	Listed	Oct 3, 2026
Alignment Health Clarity (HMO C-SNP)	Alignment Health Plan	Listed	Oct 3, 2026
Alignment Health Harmony (HMO)	Alignment Health Plan	Listed	Oct 3, 2026
Alignment Health Heart & Diabetes (HMO C-SNP)	Alignment Health Plan	Listed	Oct 3, 2026
Alignment Health Heart & Diabetes CalPlus (HMO C-SNP)	Alignment Health Plan	Listed	Oct 3, 2026
Alignment Health Heart & Diabetes Care (HMO C-SNP)	Alignment Health Plan	Listed	Sep 28, 2026
Alignment Health Heart & Diabetes Choice (HMO C-SNP)	Alignment Health Plan	Listed	Sep 28, 2026
Alignment Health Honor+ Plan (HMO)	Alignment Health Plan	Listed	Oct 3, 2026
Alignment Health My Choice CalCare (HMO)	Alignment Health Plan	Listed	Oct 3, 2026

California Medical Board record

Licence G82086 · Current

Licensed to practise in California · since 1995 · expires 2027-07-31 · University of Colorado School of Medicine.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Hospitals they work in

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

UCSF Medical CenterSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of University of California Health, which runs 12 hospitalsHome of UCSF Helen Diller Family Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 81% would definitely recommend it
Overall rating: 4 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 4.9 (3.79 to 6.02) · 7,590 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 12.8 (11.3 to 14.4) · 2,019 cases, Jan 2024 – Dec 2024Better than the national rate — Death rate among surgical inpatients with serious treatable complications: 139.4 (110.22 to 168.58) · 452 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.622, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.626, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.491, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.8 (0.7 to 1) · 2,336 cases, Jan 2024 – Dec 2024

See every measure and the patient survey for UCSF Medical Center

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 3 better, 5 the same, 3 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Sort by

Every scored measure at UCSF Medical Center

Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths	4.9 (3.79 to 6.02) · 7,590 cases	Worse	Jul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits	12.8 (11.3 to 14.4) · 2,019 cases	Worse	Jan 2024 – Dec 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths	139.4 (110.22 to 168.58) · 452 cases	Better	Jul 2022 – Jun 2024
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections	0.622	Better	Oct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections	0.626	Better	Oct 2024 – Sep 2025
MRSA BacteremiaInfections	0.491	Better	Oct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits	0.8 (0.7 to 1) · 2,336 cases	Better	Jan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths	1.24 (0.58 to 1.9) · 4,689 cases	No different	Jul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths	1.05 (0.89 to 1.2)	No different	Jul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths	1.9 · 89 cases	None	Jul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths	7.5 · 85 cases	None	Jul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths	10.1 · 132 cases	None	Jul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths	6.6 · 454 cases	None	Jul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths	10.3 · 618 cases	None	Jul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths	9.6 · 380 cases	None	Jul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths	2.7 · 5,000 cases	None	Jul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths	0.22 (0.06 to 0.38) · 15,965 cases	No different	Jul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths	0.2 (0.05 to 0.35) · 17,859 cases	No different	Jul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths	0.85 (0 to 1.83) · 4,184 cases	No different	Jul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths	2 (1.1 to 2.9) · 6,516 cases	No different	Jul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths	7.35 (4.49 to 10.21) · 3,989 cases	No different	Jul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths	5 (3.22 to 6.77) · 4,087 cases	No different	Jul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths	1.95 (0.74 to 3.15) · 2,034 cases	No different	Jul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths	0.95 (0.63 to 1.28) · 15,431 cases	No different	Jul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths	4 · 399 cases	None	Apr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections	0.899	No different	Oct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections	0.689	No different	Oct 2024 – Sep 2025
SSI - Colon SurgeryInfections	1.224	No different	Oct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits	16 · 156 cases	None	Jul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits	20 · 564 cases	None	Jul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits	60.3 · 160 cases	None	Jul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits	-9.7 · 550 cases	None	Jul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits	44.1 · 660 cases	None	Jul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits	16.8 · 667 cases	None	Jul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits	5.7 (4.8 to 6.7) · 2,019 cases	No different	Jan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits	6 · 421 cases	None	Jul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits	10.5 · 53 cases	None	Jul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits	20 · 107 cases	None	Jul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits	13.9 (11.3 to 17.1) · 3,247 cases	No different	Jan 2022 – Dec 2024

What patients said (3,181 patients answered, 25% of those asked)

Sort by

Patient survey stars by topic at UCSF Medical Center

Cleanliness	4
Nurse communication	4
Doctor communication	4
Communication about medicines	3
Discharge information	4
Overall hospital rating	4
Quietness	2
Recommend hospital	5

Sort by

Share of patients giving the best answer at UCSF Medical Center

Room was "always" clean	71%
Nurses "always" communicated well	80%
Doctors "always" communicated well	80%
Staff "always" explained	61%
Yes, staff "did" give patients this information	88%
Yes, staff "did" give patients information about help after discharge	87%
Doctors "always" explained things so they could understand	74%
Doctors "always" listened carefully	78%
Doctors "always" treated them with courtesy and respect	86%
Patients who gave a rating of "9" or "10" (high)	76%
Staff "always" explained new medications	75%
Nurses "always" explained things so they could understand	77%
Nurses "always" listened carefully	78%
Nurses "always" treated them with courtesy and respect	86%
"Always" quiet at night	50%
"YES", patients would definitely recommend the hospital	81%
Staff "always" explained possible side effects	46%
Yes, staff "did" give patients information about possible symptoms	90%

Original Medicare doctor bills

$66,400

Medicare paid this office $66,400 for 275 people. Most of that is long return visits and Botox.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Sort by

Largest Original Medicare bills

Long return visit (40+ min)	180	$43,106	$117
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes	33	$5,651	$67
New patient visit (60+ min)	24	$3,529	$147
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes	12	$2,601	$104
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes	22	$2,354	$107

See all 7 services

Sort by

Every Original Medicare service billed

Long return visit (40+ min)	180	$43,106	$117
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes	33	$5,651	$67
New patient visit (60+ min)	24	$3,529	$147
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes	12	$2,601	$104
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes	22	$2,354	$107
Telephone medical discussion with physician, 21-30 minutes	15	$1,927	$84
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	96	$1,848	$15

Who their Medicare patients are

275 Original Medicare patients in 2024. Average age 62 · Under 65 44% · Women 51% · Also on Medicaid 55% · Health risk score 4.40. Above the middle of the specialty; the typical nephrology clinician is at 4.01.

Conditions among them: High blood pressure 75% · Chronic kidney disease 75% · Diabetes 61% · Coronary heart disease 39% · Heart failure 34% · Atrial fibrillation 24% · Depression 21% · COPD 12% · Stroke 9% · Cancer 8% · Dementia 7%.

The office billed $418,228, Medicare allowed $89,293 and paid $66,400; for 743 services of 16 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Sort by

Original Medicare by year

2024	275	743	62	4.40	$418,228	$66,400
2023	354	1,023	60	5.09	$630,811	$100,636
2022	308	699	61	4.63	$457,040	$72,107
2021	284	689	61	3.89	$483,412	$79,496
2020	311	734	60	4.35	$486,769	$69,507
2019	339	663	59	4.97	$455,228	$65,962
2018	294	533	60	4.08	$359,012	$52,984
2017	260	467	60	3.82	$307,344	$44,656
2016	470	967	57	4.77	$640,560	$90,609
2015	473	1,032	56	5.46	$574,394	$96,973
2014	232	571	55	5.33	$198,237	$51,543
2013	211	597	53	5.58	$180,621	$53,919

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 9 services

Sort by

Original Medicare services billed in 2023

Long return visit (40+ min)	188	$47,732	$123
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes	59	$17,938	$105
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes	56	$7,883	$70
New patient visit (60+ min)	35	$5,442	$155
Initial hospital care with moderate level of medical decision making at least 75 minutes	32	$4,935	$150
Dialysis procedure including 1 evaluation	11	$2,744	$78
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes	22	$2,561	$116
Telephone medical discussion with physician, 21-30 minutes	11	$1,227	$88
Return visit (30+ min)	17	$1,085	$64

2022: 7 services

Sort by

Original Medicare services billed in 2022

Long return visit (40+ min)	156	$35,853	$116
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes	69	$19,043	$90
New patient visit (60+ min)	31	$4,162	$134
Telephone medical discussion with physician, 21-30 minutes	17	$2,810	$88
Long return visit (40+ min)	14	$1,680	$112
Return visit (30+ min)	17	$1,488	$83
Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes	12	$1,043	$87

2021: 5 services

Sort by

Original Medicare services billed in 2021

Long return visit (40+ min)	182	$51,412	$126
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes	42	$11,516	$91
Long return visit (40+ min)	29	$4,706	$147
New patient visit (60+ min)	24	$3,962	$165
Dialysis procedure including 1 evaluation	14	$2,922	$79

2020: 10 services

Sort by

Original Medicare services billed in 2020

Long return visit (40+ min)	155	$31,705	$98
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes	38	$10,970	$96
Long return visit (40+ min)	51	$6,431	$109
Initial hospital care with moderate level of medical decision making at least 75 minutes	21	$3,666	$175
Return visit (30+ min)	37	$2,935	$67
New patient visit (60+ min)	18	$2,455	$136
Extended patient service without direct patient contact, first hour	24	$2,289	$95
Return visit (30+ min)	11	$983	$82
Telephone medical discussion with physician, 11-20 minutes	14	$789	$46
Telephone medical discussion with physician, 11-20 minutes	12	$759	$63

2019: 6 services

Sort by

Original Medicare services billed in 2019

Long return visit (40+ min)	208	$26,796	$94
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes	73	$20,839	$93
Initial hospital care with moderate level of medical decision making at least 75 minutes	23	$5,092	$182
New patient visit (60+ min)	26	$3,511	$135
Long return visit (40+ min)	16	$1,837	$115
Extended patient service without direct patient contact, first hour	11	$1,020	$93

2018: 4 services

Sort by

Original Medicare services billed in 2018

Long return visit (40+ min)	216	$26,400	$96
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes	52	$16,397	$93
Initial hospital care with moderate level of medical decision making at least 75 minutes	26	$5,221	$180
Return visit (30+ min)	11	$757	$69

2017: 6 services

Sort by

Original Medicare services billed in 2017

Long return visit (40+ min)	165	$20,509	$97
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes	45	$11,528	$92
Initial hospital care with moderate level of medical decision making at least 75 minutes	18	$3,256	$181
New patient visit (60+ min)	12	$1,708	$142
Return visit (30+ min)	22	$1,437	$65
Needle biopsy of kidney	12	$1,301	$108

2016: 9 services

Sort by

Original Medicare services billed in 2016

Long return visit (40+ min)	271	$38,352	$96
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes	101	$27,392	$92
New patient visit (60+ min)	45	$6,038	$134
Return visit (30+ min)	66	$4,581	$66
Needle biopsy of kidney	30	$3,805	$123
Initial hospital care with moderate level of medical decision making at least 75 minutes	20	$3,520	$176
Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes	16	$1,366	$85
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes	11	$704	$64
Short return visit (20+ min)	15	$618	$39

2015: 10 services

Sort by

Original Medicare services billed in 2015

Subsequent hospital care with moderate levelof medical decision making at least 50 minutes	117	$36,754	$92
Long return visit (40+ min)	255	$32,044	$96
New patient visit (60+ min)	61	$8,595	$141
Initial hospital care with moderate level of medical decision making at least 75 minutes	23	$4,033	$175
Return visit (30+ min)	53	$3,916	$70
Needle biopsy of kidney	21	$2,880	$131
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes	21	$2,715	$65
Long return visit (40+ min)	14	$1,217	$87
Short return visit (20+ min)	12	$596	$46
Short return visit	12	$263	$22

2014: 8 services

Sort by

Original Medicare services billed in 2014

Subsequent hospital care with moderate levelof medical decision making at least 50 minutes	73	$17,273	$84
Long return visit (40+ min)	133	$15,786	$84
Long return visit (40+ min)	34	$6,297	$117
Initial hospital care with moderate level of medical decision making at least 75 minutes	27	$4,625	$159
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes	21	$2,325	$111
Needle biopsy of kidney	17	$1,841	$108
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes	12	$1,047	$58
Ultrasonic guidance for needle placement	16	$437	$27

2013: 7 services

Sort by

Original Medicare services billed in 2013

Subsequent hospital care with moderate levelof medical decision making at least 50 minutes	62	$18,323	$81
Long return visit (40+ min)	129	$17,844	$85
Long return visit (40+ min)	35	$5,884	$120
Initial hospital care with moderate level of medical decision making at least 75 minutes	32	$5,398	$159
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes	12	$1,301	$57
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes	12	$1,215	$101
Needle biopsy of kidney	11	$1,139	$104

Medicaid work

$37,053 in 2024

Medicaid paid $37,053 for 394 billed services this clinician did in 2024, up to 35 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Sort by

Largest Medicaid services in 2024

Long return visit (40+ min)	241	$29,064
SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES	113	$5,255
New patient visit (60+ min)	14	$2,530
Telehealth transmission, per minute, professional services bill separately	26	$205

Sort by

Medicaid work by year

2024	394	4	35	$37,053
2023	450	4	39	$42,740
2022	268	3	29	$29,593
2021	189	1	25	$17,650
2020	212	2	24	$12,350
2019	65	1	18	$6,899
2018	135	1	22	$12,466

See the largest Medicaid services in earlier years

2023

Sort by

Largest Medicaid services in 2023

Long return visit (40+ min)	321	$36,781
SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES	46	$3,433
SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES	56	$2,250
Telehealth transmission, per minute, professional services bill separately	27	$276

2022

Sort by

Largest Medicaid services in 2022

Long return visit (40+ min)	209	$25,533
SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES	47	$4,024
Hospital outpatient clinic visit for assessment and management of a patient	12	$37

2021

Sort by

Largest Medicaid services in 2021

Long return visit (40+ min)	189	$17,650

2020

Sort by

Largest Medicaid services in 2020

Long return visit (40+ min)	182	$10,840
SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES	30	$1,510

2019

Sort by

Largest Medicaid services in 2019

Long return visit (40+ min)	65	$6,899

2018

Sort by

Largest Medicaid services in 2018

Long return visit (40+ min)	135	$12,466

Drugs they prescribed that Part D paid

$122,290

Pharmacies billed $122,290 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

1,076 generic and 89 brand-name prescriptions · $122,290 in drug cost · 71 antibiotic prescriptions to 34 people.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Sort by

Largest Part D drug costs

Lokelma	24	$31,306	$1,304
Tacrolimus	89	$12,933	$145
Cinacalcet	48	$8,819	$184
Mycophenolate Mofetil	65	$8,115	$125
Valganciclovir	33	$7,340	$222

See all 18 drugs

Sort by

Every Part D drug this clinician prescribed

Lokelma	24	$31,306	$1,304
Tacrolimus	89	$12,933	$145
Cinacalcet	48	$8,819	$184
Mycophenolate Mofetil	65	$8,115	$125
Valganciclovir	33	$7,340	$222
Mycophenolic Acid	27	$3,169	$117
Methenamine Hippurate	35	$2,843	$81
Prednisone	357	$2,207	$6
Nifedipine Er	16	$635	$40
Fluconazole	22	$468	$21
Omeprazole	38	$277	$7
Carvedilol	31	$257	$8
Sulfamethoxazole-Trimethoprim	49	$242	$5
Tamsulosin	23	$208	$9
Amlodipine Besylate	19	$81	$4
Clonidine	14	$73	$5
Furosemide	18	$49	$3
Ciprofloxacin	12	$43	$4

Year by year

Sort by

Part D prescribing by year

2024	1,180	256	None	8%	$122,290
2023	1,395	271	None	8%	$322,491
2022	1,384	289	None	9%	$257,592
2021	1,819	334	None	9%	$302,738
2020	2,025	376	None	10%	$326,831
2019	1,628	324	None	15%	$365,335
2018	1,027	232	None	16%	$246,373
2017	1,087	274	None	14%	$257,542
2016	1,584	328	None	14%	$346,761
2015	1,771	311	None	15%	$309,930
2014	1,490	253	None	18%	$312,717
2013	1,067	190	None	17%	$172,087

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 26 drugs

Sort by

Part D drugs prescribed in 2023

Cinacalcet	75	$77,668	$1,036
Tacrolimus	117	$39,111	$334
Lokelma	28	$34,543	$1,234
Envarsus Xr	12	$31,614	$2,634
Valganciclovir	39	$11,607	$298
Mycophenolate Mofetil	65	$9,905	$152
Mycophenolic Acid	18	$5,770	$321
Methenamine Hippurate	46	$4,453	$97
Entecavir	24	$2,451	$102
Humalog Kwikpen U-100	12	$2,353	$196
Prednisone	301	$2,247	$7
Tamsulosin	26	$1,148	$44
Nifedipine Er	24	$1,035	$43
Fluconazole	26	$813	$31
Losartan	18	$683	$38
Hydralazine	28	$649	$23
Omeprazole	52	$639	$12
Ultra-Fine Nano Pen Needle	13	$573	$44
Amlodipine Besylate	34	$560	$16
Carvedilol	38	$537	$14
Sulfamethoxazole-Trimethoprim	53	$510	$10
Metoprolol	26	$319	$12
Calcitriol	13	$219	$17
Potassium Chloride	19	$201	$11
Furosemide	17	$163	$10
Ciprofloxacin	23	$126	$5

2022: 28 drugs

Sort by

Part D drugs prescribed in 2022

Cinacalcet	63	$55,794	$886
Valganciclovir	51	$40,125	$787
Tacrolimus	127	$35,737	$281
Mycophenolic Acid	58	$21,463	$370
Lokelma	18	$20,708	$1,150
Humalog Kwikpen U-100	15	$6,321	$421
Mycophenolate Mofetil	55	$5,313	$97
Methenamine Hippurate	54	$5,306	$98
Envarsus Xr	12	$4,552	$379
Lantus Solostar	12	$3,325	$277
Nano 2nd Gen Pen Needle	16	$2,232	$139
Prednisone	264	$1,816	$7
Fluconazole	40	$1,398	$35
Sulfamethoxazole-Trimethoprim	90	$1,176	$13
Omeprazole	64	$993	$16
Entecavir	13	$970	$75
Nifedipine Er	16	$722	$45
Tamsulosin	23	$423	$18
Hydralazine	21	$362	$17
Carvedilol	41	$339	$8
Losartan	29	$277	$10
Metoprolol	28	$226	$8
Amlodipine Besylate	24	$218	$9
Furosemide	17	$188	$11
Rosuvastatin	13	$185	$14
Pantoprazole	16	$162	$10
Potassium Chloride	20	$142	$7
Ciprofloxacin	13	$67	$5

2021: 31 drugs

Sort by

Part D drugs prescribed in 2021

Cinacalcet	85	$72,496	$853
Valganciclovir	55	$35,990	$654
Lokelma	26	$27,249	$1,048
Tacrolimus	117	$24,338	$208
Mycophenolic Acid	40	$13,230	$331
Novolog Flexpen	12	$8,842	$737
Mycophenolate Mofetil	101	$8,035	$80
Methenamine Hippurate	81	$7,291	$90
Lamivudine Hbv	14	$4,830	$345
Lantus Solostar	12	$3,293	$274
Envarsus Xr	14	$3,217	$230
Nano 2nd Gen Pen Needle	22	$2,915	$132
Prednisone	234	$1,655	$7
Nifedipine Er	27	$1,338	$50
Omeprazole	106	$1,118	$11
Losartan	53	$990	$19
Sulfamethoxazole-Trimethoprim	105	$564	$5
Carvedilol	53	$514	$10
Pantoprazole	20	$479	$24
Gabapentin	48	$422	$9
Hydralazine	19	$289	$15
Tamsulosin	21	$285	$14
Amlodipine Besylate	41	$281	$7
Fluconazole	28	$254	$9
Atorvastatin	36	$244	$7
Lisinopril	25	$226	$9
Metoprolol	32	$202	$6
Furosemide	41	$199	$5
Ciprofloxacin	18	$103	$6
Metformin	15	$92	$6
Glipizide	11	$77	$7

2020: 40 drugs

Sort by

Part D drugs prescribed in 2020

Tacrolimus	185	$63,695	$344
Cinacalcet	71	$58,966	$831
Valganciclovir	49	$25,178	$514
Mycophenolic Acid	29	$15,511	$535
Mycophenolate Mofetil	139	$14,759	$106
Humalog Kwikpen U-100	19	$9,060	$477
Methenamine Hippurate	53	$7,088	$134
Novolog Flexpen	15	$7,053	$470
Xarelto	11	$5,523	$502
Lantus Solostar	18	$4,482	$249
Nifedipine Er	59	$2,900	$49
Cyclosporine Modified	11	$1,636	$149
Prednisone	248	$1,611	$6
Ultra-Fine Nano Pen Needle	11	$1,264	$115
Omeprazole	112	$1,082	$10
Labetalol	12	$1,000	$83
Ultra-Fine Short Pen Needle	12	$939	$78
Pantoprazole	32	$794	$25
Calcitriol	22	$758	$34
Tamsulosin	51	$689	$14
Sulfamethoxazole-Trimethoprim	88	$622	$7
Metoprolol	94	$527	$6
Atorvastatin	42	$423	$10
Metoprolol	24	$383	$16
Furosemide	37	$350	$9
Carvedilol	27	$346	$13
Amlodipine Besylate	39	$317	$8
Losartan	28	$305	$11
Gabapentin	19	$208	$11
Hydralazine	14	$200	$14
Fluconazole	18	$170	$9
Simvastatin	14	$165	$12
Lisinopril	26	$140	$5
Glipizide	18	$119	$7
Potassium Chloride	13	$119	$9
Glipizide Er	14	$110	$8
Finasteride	16	$91	$6
Ciprofloxacin	12	$74	$6
Pravastatin	15	$67	$4
Atenolol	12	$65	$5

2019: 32 drugs

Sort by

Part D drugs prescribed in 2019

Sensipar	47	$63,585	$1,353
Valganciclovir	73	$62,426	$855
Cinacalcet	17	$33,290	$1,958
Nulojix	12	$24,104	$2,009
Tacrolimus	69	$16,735	$243
Mycophenolate Mofetil	51	$13,259	$260
Humalog Kwikpen U-100	18	$8,017	$445
Novolog	13	$7,703	$593
Methenamine Hippurate	44	$4,995	$114
Lantus Solostar	11	$3,373	$307
Nifedipine Er	38	$1,692	$45
Prednisone	210	$1,450	$7
Omeprazole	102	$1,399	$14
Ultra-Fine Nano Pen Needle	13	$1,146	$88
Metolazone	16	$867	$54
Tamsulosin	52	$721	$14
Sulfamethoxazole-Trimethoprim	100	$630	$6
Pantoprazole	27	$611	$23
Hydralazine	20	$557	$28
Metoprolol	86	$537	$6
Fluconazole	47	$478	$10
Carvedilol	28	$451	$16
Furosemide	43	$435	$10
Losartan	37	$365	$10
Finasteride	22	$323	$15
Simvastatin	16	$280	$18
Atorvastatin	23	$255	$11
Lisinopril	24	$218	$9
Amlodipine Besylate	25	$181	$7
Glipizide	17	$148	$9
Clonidine	13	$102	$8
Ciprofloxacin	15	$85	$6

2018: 28 drugs

Sort by

Part D drugs prescribed in 2018

Valganciclovir	50	$69,732	$1,395
Sensipar	27	$35,574	$1,318
Lamivudine Hbv	45	$12,528	$278
Leflunomide	12	$7,219	$602
Humalog	18	$4,041	$225
Mycophenolate Mofetil	13	$3,504	$270
Methenamine Hippurate	19	$3,442	$181
Tacrolimus	11	$2,114	$192
Dapsone	16	$2,107	$132
Labetalol	15	$1,712	$114
Tamsulosin	72	$1,307	$18
Prednisone	82	$1,148	$14
Omeprazole	81	$992	$12
Nifedipine Er	17	$548	$32
Sulfamethoxazole-Trimethoprim	50	$396	$8
Metoprolol	55	$383	$7
Acyclovir	11	$292	$27
Lisinopril	32	$263	$8
Calcium Acetate	12	$262	$22
Simvastatin	18	$248	$14
Furosemide	32	$226	$7
Finasteride	26	$221	$9
Fluconazole	25	$214	$9
Losartan	18	$199	$11
Gabapentin	11	$190	$17
Amlodipine Besylate	26	$141	$5
Famotidine	17	$118	$7
Ciprofloxacin	17	$109	$6

2017: 26 drugs

Sort by

Part D drugs prescribed in 2017

Valganciclovir	46	$102,533	$2,229
Tivicay	13	$19,703	$1,516
Sensipar	19	$16,753	$882
Leflunomide	11	$6,716	$611
Emtriva	12	$6,431	$536
Methenamine Hippurate	29	$6,186	$213
Lamivudine Hbv	16	$4,900	$306
Tacrolimus	29	$4,820	$166
Prednisone	184	$3,143	$17
Mycophenolate Mofetil	12	$2,656	$221
Tamsulosin	41	$1,145	$28
Ultra-Fine Nano Pen Needle	15	$684	$46
Labetalol	14	$613	$44
Omeprazole	70	$585	$8
Losartan	34	$451	$13
Sulfamethoxazole-Trimethoprim	47	$396	$8
Amlodipine Besylate	54	$327	$6
Fluconazole	27	$283	$10
Azithromycin	16	$266	$17
Atorvastatin	14	$264	$19
Metoprolol	34	$245	$7
Lisinopril	32	$215	$7
Doxazosin Mesylate	12	$164	$14
Ciprofloxacin	20	$141	$7
Furosemide	26	$109	$4
Carvedilol	14	$93	$7

2016: 28 drugs

Sort by

Part D drugs prescribed in 2016

Valganciclovir	68	$174,741	$2,570
Tacrolimus	50	$11,162	$223
Lantus Solostar	24	$9,492	$396
Methenamine Hippurate	39	$6,516	$167
Lamivudine Hbv	19	$6,376	$336
Prednisone	261	$4,668	$18
Mycophenolate Mofetil	21	$3,644	$174
Dapsone	13	$2,059	$158
Tamsulosin	60	$1,823	$30
Humalog Kwikpen U-100	15	$1,743	$116
Nifedipine Er	38	$1,418	$37
Bd Ultra-Fine Pen Needle	28	$1,365	$49
Acyclovir	24	$1,329	$55
Omeprazole	102	$1,310	$13
Sulfamethoxazole-Trimethoprim	78	$949	$12
Labetalol	20	$767	$38
Amlodipine Besylate	96	$639	$7
Carvedilol	40	$584	$15
Fluconazole	49	$494	$10
Hydralazine	22	$446	$20
Pravastatin	24	$366	$15
Losartan	15	$276	$18
Metoprolol	51	$272	$5
Ciprofloxacin	20	$214	$11
Allopurinol	11	$186	$17
Atorvastatin	14	$142	$10
Lisinopril	19	$108	$6
Furosemide	27	$98	$4

2015: 36 drugs

Sort by

Part D drugs prescribed in 2015

Valganciclovir	46	$135,816	$2,953
Sensipar	26	$24,149	$929
Tacrolimus	45	$18,903	$420
Lantus	45	$11,842	$263
Procrit	11	$11,331	$1,030
Pravastatin	142	$3,593	$25
Nexium	16	$3,467	$217
Mycophenolate Mofetil	23	$1,943	$84
Tamsulosin	57	$1,460	$26
Omeprazole	122	$1,383	$11
Carvedilol	34	$1,316	$39
Bd Ultra-Fine Pen Needle	25	$926	$37
Kionex	13	$869	$67
Prednisone	105	$864	$8
Phospha 250 Neutral	12	$828	$69
Hydralazine	22	$789	$36
Amlodipine Besylate	129	$633	$5
Metoprolol	28	$471	$17
Sulfamethoxazole-Trimethoprim	56	$463	$8
Metoprolol	105	$451	$4
Pantoprazole	40	$411	$10
Acyclovir	13	$391	$30
Insulin	27	$382	$14
Carbidopa-Levodopa	12	$378	$31
Famotidine	58	$344	$6
Potassium Chloride	11	$316	$29
Fluconazole	31	$259	$8
Ciprofloxacin	26	$196	$8
Allopurinol	20	$142	$7
Oxybutynin Chloride	11	$141	$13
Clopidogrel	15	$130	$9
Warfarin	13	$119	$9
Furosemide	39	$111	$3
Clonidine	26	$97	$4
Gabapentin	15	$84	$6
Insulin	14	$33	$2

2014: 33 drugs

Sort by

Part D drugs prescribed in 2014

Valcyte	31	$79,945	$2,579
Sensipar	39	$30,216	$775
Procrit	14	$11,284	$806
Tacrolimus	20	$6,549	$327
Lantus	20	$5,575	$279
Pravastatin	235	$4,938	$21
Advair Hfa	11	$3,200	$291
Mycophenolate Mofetil	27	$3,196	$118
Nexium	15	$2,196	$146
Kionex	16	$1,275	$80
Omeprazole	98	$1,122	$11
Leflunomide	15	$1,021	$68
Tamsulosin	36	$888	$25
Phospha 250 Neutral	16	$868	$54
Hydralazine	28	$865	$31
Amlodipine Besylate	157	$834	$5
Bd Ultra-Fine Pen Needle	23	$792	$34
Labetalol	14	$654	$47
Famotidine	85	$613	$7
Metoprolol	71	$592	$8
Pantoprazole	28	$459	$16
Metoprolol	17	$391	$23
Carvedilol	38	$358	$9
Potassium Chloride	13	$338	$26
Prednisone	44	$333	$8
Clonidine	29	$176	$6
Allopurinol	28	$146	$5
Glipizide	20	$108	$5
Insulin	14	$99	$7
Ciprofloxacin	12	$85	$7
Minoxidil	13	$82	$6
Furosemide	18	$48	$3
Sulfamethoxazole-Trimethoprim	13	$40	$3

2013: 25 drugs

Sort by

Part D drugs prescribed in 2013

Valcyte	15	$33,470	$2,231
Sensipar	28	$20,966	$749
Procrit	17	$12,266	$722
Tacrolimus	15	$5,798	$387
Sps	17	$2,283	$134
Lantus	11	$2,170	$197
Pravastatin	114	$1,648	$14
Kionex	15	$1,645	$110
Omeprazole	92	$1,275	$14
Mycophenolate Mofetil	14	$1,030	$74
Potassium Chloride	16	$739	$46
Amlodipine Besylate	82	$675	$8
Tamsulosin	24	$663	$28
Famotidine	77	$627	$8
Hydralazine	23	$608	$26
Pantoprazole	24	$472	$20
Metoprolol	43	$434	$10
Carbidopa-Levodopa	12	$420	$35
Carvedilol	22	$286	$13
Lisinopril	23	$160	$7
Prednisone	48	$150	$3
Ciprofloxacin	16	$134	$8
Sulfamethoxazole-Trimethoprim	11	$124	$11
Clonidine	17	$100	$6
Furosemide	20	$78	$4

Money from drug and device companies

$3,575 in 2025

Sort by

Industry payments by year

2025	1	1	$3,575	$3,575
2022	1	1	None	$130
2021	2	2	$4,760	$4,868
2019	2	2	None	$233

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Sort by

Payments by company

Vertex Pharmaceuticals	None	$3,575	1 payment Consulting · 2025-07-03 · $3,575

See the published payment

Sort by

Every published payment

Vertex Pharmaceuticals	Consulting · 2025-07-03	None	$3,575

See earlier years (2022, 2021, 2019)

2022: $130

Sort by

Payments by company in 2022

Veloxis Pharmaceuticals	Envarsus	$130	1 payment Meals for Envarsus · 2022-08-05 · $130

2021: $4,868

Sort by

Payments by company in 2021

Otsuka Pharmaceutical Development & Commercialization	None	$4,760	1 payment Consulting · 2021-08-05 · $4,760
Fresenius USA Marketing	Velphoro	$108	1 payment Meals for Velphoro · 2021-10-28 · $108

2019: $233

Sort by

Payments by company in 2019

Veloxis Pharmaceuticals	Envarsus	$134	1 payment Meals for Envarsus · 2019-03-12 · $134
E.R. Squibb & Sons L.L.C.	Nulojix	$99	1 payment Meals for Nulojix · 2019-10-24 · $99

Research money

Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.

Sort by

Research payments by company and study

E.R. Squibb & Sons, L.L.C. · Evaluation of the Benefits and Risks in Maintenance Renal Transplant Recipients Following Conversion To Nulojix (Belatacept)-Based Immunosuppression · 2020	Their institution	$699

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score: 82.3 / 100; Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI: 1609823459
Licence: CA G82086California G82086: Current · expires 2027-07-31
Trained: University of Colorado School of Medicine, Denver, 1989
Group: Regents of the University of California
Video visits: Lists video visits
Gender: Female

More record details

Sole proprietor: No
Medicaid ID: CA 00G820860
Taxonomy: Federal specialty code 207RN0300X (207RN0300X); Internal medicine (207R00000X)
Mailing address: 2233 Stockton Blvd, Sacramento, CA, 95817
NPI first listed: 2006-05-27
NPI last updated: 2011-08-10

This is when the NPI record was last certified, not a medical board exam.